GlassScriptPhysician profile
Mohammad F Khalil
NPI 1164460481
$7,032.94
in general payments reported to CMS, 2019-2025
37 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,420 · 2020: $441 · 2021: $330 · 2022: $938 · 2023: $1,857 · 2024: $493 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323 · Travel and Lodging: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,323.05 |
| Travel and Lodging | $580.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,261.40 | 2019-2025 | Invision, Prophecy, Inbone |
| Integra Lifesciences Corporation | $676.14 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $443.06 | 2019-2025 | Grafix Pl, Stravix, Stravix Pl |
| Bsn Medical INC | $280.30 | 2023 | |
| Medtronic, INC. | $271.28 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Paragon 28, INC. | $233.90 | 2019-2025 | Silverback |
| Depuy Synthes Sales INC. | $207.45 | 2022-2025 | Na, Va-Lcp, Motoband Cp |
| Pinnacle, INC | $184.33 | 2019-2020 | |
| Kerecis Limited | $171.89 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $156.25 | 2024-2025 | |
| Osiris Therapeutics INC. | $128.77 | 2019 | |
| Sanara Medtech INC. | $120.74 | 2023 | Celleraterx |
| Glaxosmithkline, LLC. | $99.95 | 2022 | |
| Zimmer Biomet Holdings, INC. | $96.54 | 2019-2020 | |
| Organogenesis INC. | $88.39 | 2021-2025 | Puraply Wound Matrix |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $82.81 | 2024-2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $61.97 | 2021-2022 | |
| Tactile Systems Technology INC | $43.87 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Axogen | $39.94 | 2019 | |
| Amgen INC. | $38.32 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $37.12 | 2022 | |
| Nevro Corp. | $32.26 | 2024 | Senza |
| Medartis INC. | $29.10 | 2021 | |
| Acell, INC. | $26.91 | 2019-2020 | |
| Linvatec Corporation | $23.62 | 2021 | |
| Heron Therapeutics, INC. | $22.46 | 2024 | Zynrelef |
| Baxter Healthcare | $20.23 | 2020 | |
| Trice Medical, INC. | $19.32 | 2024 | |
| Grt US Holding, INC. | $18.64 | 2022 | |
| Convatec INC. | $18.32 | 2021 | |
| Nabriva Therapeutics, Plc | $17.21 | 2021 | |
| Bioventus LLC | $16.11 | 2023 | Exogen Ultrasound Bone Healing System |
| Hartmann USA, INC. | $14.46 | 2024 | Zetuvit Plus 10x10 P10 |
| Wright Medical Technology, INC. | $14.29 | 2019 | |
| Kci USA, INC. | $13.94 | 2021 | |
| Arthrosurface Incorporated | $11.45 | 2019 | |
| Orthofix Medical, INC. | $10.20 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.